BioConnect

Toronto, Canada Founded: 2009 • Age: 17 yrs Acquired By Gentex
Biometrics hardware and software integration is managed through BioConnects platform.

About BioConnect

BioConnect is a Technology company based in Toronto (Canada) founded in 2009, and was acquired by Gentex in November 2025. Biometrics hardware and software integration is managed through BioConnects platform. It operates in the Technology, Industrial Goods & Manufacturing, and Financial Services sectors. BioConnect has raised $3.9 million across 2 funding rounds from investors including Gentex, BDC and FedDev Ontario. BioConnect has completed 2 acquisitions, including MedixSafe and Silent Partner Technologies. BioConnect offers products and services including Arc Vision, Arc Touch, and BioEntry W3. Its focus areas include Enterprise Infrastructure, Cybersecurity, IAM and Biometrics. Its legal entity is BioConnect Inc.

Company details

BioConnect was founded in 2009 in Toronto, Canada, and operates in the biometrics and identity access management sector. A platform for integrating biometrics hardware and software is offered, along with lifecycle management tools. BioConnect ID serves as the core product, enabling organizations to unify multiple biometric solutions for enterprise authentication, data center security, and time and attendance monitoring. Operations focus on secure hardware integration across various environments.

  • Headquarters Toronto, Canada
  • Stage Acquired
  • Sectors
    Technology
    Industrial Goods & Manufacturing Financial Services
  • Website bioconnect.com
  • Social LinkedIn X Facebook YouTube
  • Acquired by Gentex (Nov 2025)
  • Legal Name Bioconnect Inc.
Key Metrics
  • Total Equity Funding
    $3.9M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.5M (USD), Debt – Conventional

    Jul 2020

  • Investors
    Gentex

    & 2 more

  • Investments & Acquisitions
    MedixSafe

    & 1 more

  • Acquired by
    Gentex

    (Nov 2025)

Products & Services of BioConnect

BioConnect offers a comprehensive portfolio of products and services, including Arc Vision, Arc Touch, and BioEntry W3.

Arc Vision
Biometric Device

AI-optimized facial authentication for secure access control.

Arc Touch
Biometric Device

Fingerprint reader with WiFi for indoor and outdoor use.

BioEntry W3
Biometric Device

Advanced facial authentication device for identity verification.

Apps and channels of BioConnect

its YouTube channel BioConnect has 7.65K subscribers and 30 videos.

BioConnect
YouTube 7.65K subscribers 30 videos Science & Technology
Open channel

Videos from BioConnect

The most watched videos on BioConnect's YouTube channel, BioConnect (7.65K subscribers). Click a video to play it here.

MedixSafe - Narcotic Safes for First Responders
14.8K views
How to Add Devices and Access Levels in ZKAccess
9.8K views
How to Pull Logs and Personnel from a Device in ZKAccess
6.5K views
How to Migrate ZKAccess Software to a New Computer
6.4K views

More on BioConnect.

Funding Insights of BioConnect

BioConnect has successfully raised a total of $3.9M across 2 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $1.5 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3.9M
  • Total Rounds 2
  • Last Round Debt – Conventional β€” $1.5M
  • First Round $3.9M

    (Sep 2019)

  • Investors Count 2

All 2 funding rounds of BioConnect with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2020$1.5MDebt – Conventional––
Sep 2019$3.9MSeries A–FedDev Ontario
–
Valuation history

3 investors in total: 3 institutional.

Investors in BioConnect

BioConnect has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Gentex, BDC and FedDev Ontario.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Commercial banking services for small and medium-sized enterprises are provided.
1944bdc.caMontreal, Canada
It serves as a government backed investment fund focused on the economic growth of southern ontorio.
2009feddevontario.gc.caWaterloo, Canada
Gentex Corporation is engaged in developing automotive and safety technologies.
1974gentex.comZeeland, United States
Premium access

Investor details for BioConnect

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Investments & Acquisitions by BioConnect

BioConnect has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include MedixSafe and Silent Partner Technologies.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
RFID-based asset and inventory management solutions are provided.
silentpartnertech.comTampa, United States2004Jan 2024β€’β€’β€’β€’
Electronic cabinets are manufactured by MedixSafe in Memphis.
medixsafe.comMemphis, United States2009Sep 2021β€’β€’β€’β€’
Premium access

Complete acquisition details for BioConnect

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of BioConnect

6 dated milestones of BioConnect across 16 years, from founding to its latest funding, stage changes and deals.

  1. Founded BioConnect is founded.
  2. Funding First funding round of $3.9M.
  3. Funding Latest funding round, Debt – Conventional, of $1.5M.
  4. Acquisition Acquires MedixSafe.
  5. Acquisition Acquires Silent Partner Technologies.
  6. Exit Acquired by Gentex.

Web traffic of BioConnect

The website of BioConnect (bioconnect.com) receives about 9K visits a month.

  • Monthly visits
    9K

    ▲ 8.8% vs previous month

Similar websites

Websites whose visitors overlap most with BioConnect. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
xperix.com
100%
12.2K#1,882,031View details
exam-labs.com
84%
#623,558View details
switch.richard5.net
switch.richard5.net
78%
–
getkisi.com
72%
109.7K#400,168View details
connectwise.com
72%
1.3M#41,249View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 38 similar websites and full traffic analytics for BioConnect

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 38 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Bioconnect

Premium access

Complete news archive for BioConnect

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BioConnect

BioConnect was founded in 2009 and raised its 1st funding round 10 years after it was founded.

BioConnect is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.

BioConnect is a funded company, having raised a total of $3.9M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.9M, raised on Sep 2019.

BioConnect was founded in 2009 in Toronto, Canada, and operates in the biometrics and identity access management sector. A platform for integrating biometrics hardware and software is offered, along with lifecycle management tools. BioConnect ID serves as the core product, enabling organizations to unify multiple biometric solutions for enterprise authentication, data center security, and time and attendance monitoring. Operations focus on secure hardware integration across various environments.

BioConnect offers Arc Vision, Arc Touch, and BioEntry W3.

BioConnect has made 2 acquisitions, including MedixSafe, and Silent Partner Technologies.

BioConnect has 3 investors. Key investors include Gentex, BDC, and FedDev Ontario.

BioConnect operates through Bioconnect Inc..

Yes. BioConnect was acquired by Gentex in November 2025.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available